0.00Open0.00Pre Close0 Volume0 Open Interest3.00Strike Price0.00Turnover0.00%IV84.22%PremiumJul 5, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma25.35Leverage Ratio--Theta--Rho--Eff Leverage--Vega
TG Therapeutics Stock Discussion
$AGBA Group(AGBA.US)$
$TG Therapeutics(TGTX.US)$
The company said fourth quarter loss narrowed to 9 cents a share from 39 cents a year earlier. That's smaller than the 11 cents expected by analysts polled by Capital IQ, according to MT Newswires.
Revenue for the three months ende...
No comment yet